Learn about managed care policies and benefit designs from the health plan decision makers working to create them – and the clinicians who navigate them. PayerTalkCE brings you engaging discussions between payer and clinician experts on both specific conditions from atopic dermatitis to retinal disease as well as issues like social determinants of health and the impact of biosimilars. This unique look at health care in America features hosts from the cutting edge of managed care innovation and clinician experts from across the US. All PayerTalkCE podcasts are certified for free continuing education credit also, be sure to visit the show pages to earn yours.
All content for PayerTalkCE is the property of IMPACT and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Learn about managed care policies and benefit designs from the health plan decision makers working to create them – and the clinicians who navigate them. PayerTalkCE brings you engaging discussions between payer and clinician experts on both specific conditions from atopic dermatitis to retinal disease as well as issues like social determinants of health and the impact of biosimilars. This unique look at health care in America features hosts from the cutting edge of managed care innovation and clinician experts from across the US. All PayerTalkCE podcasts are certified for free continuing education credit also, be sure to visit the show pages to earn yours.
PayerTalkCE™ Presents: Understanding Type 2 Inflammation - Spotlight on Eosinophilic Esophagitis
PayerTalkCE
36 minutes 49 seconds
11 months ago
PayerTalkCE™ Presents: Understanding Type 2 Inflammation - Spotlight on Eosinophilic Esophagitis
This podcast addresses the role of type 2 inflammation in the pathophysiology and management of eosinophilic esophagitis (EoE), with a focus on evolving treatment strategies. Dr. Evan Dellon discusses the mechanisms behind EoE, the limitations of current allergy testing, and the challenges in diagnosing the condition due to non-specific symptoms. He reviews current therapeutic approaches, including dietary modifications, proton pump inhibitors, topical steroids, and biologics like dupilumab, which target specific inflammatory pathways. Emerging therapies and combination treatments are also explored, highlighting opportunities for optimizing patient outcomes in this chronic condition.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us athttps://www.impactedu.net/ (https://www.managedcarecgm.com/diabetes-quality-and-cgm)type2-inflammation-eoe-management.
PayerTalkCE
Learn about managed care policies and benefit designs from the health plan decision makers working to create them – and the clinicians who navigate them. PayerTalkCE brings you engaging discussions between payer and clinician experts on both specific conditions from atopic dermatitis to retinal disease as well as issues like social determinants of health and the impact of biosimilars. This unique look at health care in America features hosts from the cutting edge of managed care innovation and clinician experts from across the US. All PayerTalkCE podcasts are certified for free continuing education credit also, be sure to visit the show pages to earn yours.
